Protection by conventional and new antiepileptic drugs against lindane-induced seizures and lethal effects in mice.

Toxic effects caused by the organochlorine xenobiotic lindane may result from too excessive antiscabicidal treatment and in cases of accidental or intentional poisoning. Predominant symptoms of lindane intoxication concern the central nervous system, e.g.

Ethosuximide and valproate display high efficacy against lindane-induced seizures in mice.

Both lindane (gamma-hexachlorocyclohexane), an organochlorine ectoparasiticide and pentylenetetrazol, used as a model of experimental epilepsy, produce convulsive seizures resulting from the blockade of the gamma-aminobutyric acid (GABAA) receptor. In the present study we established the protective effects of ethosuximide and valproate against seizures induced by lindane and compared them with the well-known protective effects of these drugs against pentylenetetrazol-induced seizures in mice. Both ethosuximide and valproate afforded complete and dose-dependent protection against seizures induced by lindane.

Studies of toxicity of dermally-absorbed nurelle D 550 EC preparations.

The aim of the study was the evaluation of the toxic effect of a two-component, preparation Nurelle D 550 EC (500 g of chlorpyrifos and 50 g cypermethrin per 1 l), administrated dermally. Toxicity was evaluated from histological and ultrastructural studies of the internal organs and immunotoxic effects (evaluation of phagocytical and bactericidal activity of neutrophils). The preparation for dermal application was applied in 2 concentrations (200 mg/kg/day of chlorpyrifos plus 20 mg/kg/day of cypermethrin or 1000 mg/kg/day of chlorpyrifos, plus 100 mg/kg/day of cypermethrin).

Toxicity of dermally applied alpha-cypermethrin in rats.

The aim of the study was to assess the immunotoxic effect of dermally applied alpha-cypermethrin in rats based on phagocytic and bactericidal activity of neutrophils of peripheral blood, and the general toxic effect based on histological and ultrastructural examination of internal organs. The preparation was dermally applied in doses of 50 mg/kg and 250 mg/kg. It was administered to the tail skin of female Wistar rats, 4 hours daily for 28 days.